Search results
Results from the WOW.Com Content Network
It provides daily news and analysis on the biotechnology and pharmaceutical industry including areas such as policy & regulation, business news, research & development, generics, drug delivery, and clinical trials. In 2022, Informa sold its Pharma Intelligence division, including Scrip, to Warburg Pincus. [4] The business was renamed Citeline.
The Agora is a Baltimore, Maryland-based network for over thirty companies in the publishing, information services, and real estate industries. [1] [2] Agora was founded in 1978, in the Mount Vernon neighborhood of Baltimore, Maryland. [3] The Agora Companies operate independently from cities around the world.
This listing is limited to those independent companies and subsidiaries notable enough to have their own articles in Wikipedia. Both going concerns and defunct firms are included, as well as firms that were part of the pharmaceutical industry at some time in their existence, provided they were engaged in the production of human (as opposed to veterinary) therapeutics.
RSS feeds lets you subscribe to specific webpages, blogs, news headlines and more. Once you've subscribed to an RSS feed, updated info from the feed automatically downloads to your computer so that you can view updates in an easy-to-read format later on.
Walgreens booked a better-than-expected fiscal first quarter and gave Wall Street some positive vibes on the drugstore chain's plan to revive its struggling business. CEO Tim Wentworth told ...
The following table lists the largest biotechnology and pharmaceutical companies ranked by revenue in billion USD. The change column indicates the company's relative position in this list compared to its relative position in the preceding year; i.e., an increase would be moving closer to rank 1 and vice versa.
Get the latest news, politics, sports, and weather updates on AOL.com.
More: Columbus-area home prices top record high for 2023. ... Steve Nicastro, a content team leader with Clever Real Estate, based in St. Louis, said Clever expects the ruling to lead to lower ...